MS charities 'disappointed' by NICE decision on new drug

Latest

MS charities 'disappointed' by NICE decision on new drug

Latest

Multiple sclerosis charities have expressed their disappointment at NICE’s decision not to recommend the new drug ozanimod for patients in England and Wales. 

Ozanimod, which is marketed as Zeposia, is an oral treatment for relapsing-remitting MS. Since February it has been accepted for restricted use by the NHS in Scotland.

In a decision published today (May 13), NICE said that although evidence shows ozanimod reduces relapses and brain lesions in MS patients compared with interferon beta-1a – a drug currently used on the NHS – its effect on the progression of disability is “unclear”.  

NICE also said the estimated costs of prescribing ozanimod are above what it “normally considers an acceptable use of NHS resources,” especially given the limitations in the available clinical data. 

MS Society policy manager Fredi Cavander-Attwood said: “It’s disappointing that NICE has made this decision not to recommend ozanimod as a treatment for relapsing multiple sclerosis in England.

“Oral treatments like ozanimod are limited and not allowing people this option could deny them a convenient way to manage MS symptoms. 

“This rejection also highlights the inequities in access to treatments around the UK, as people living with MS in Scotland were granted access to ozanimod in February. Effective MS treatments should be made available for everyone living with MS regardless of where they live in the UK.” 

MS Trust CEO David Martin echoed these concerns, saying: “People who don’t want to or are unable to self-inject or travel to hospital infusion clinics have limited options.

“As a once daily tablet with few side effects, ozanimod offers advantages over existing treatments and would have increased choices for people with relapsing remitting MS and their doctors.

The NICE decision comes weeks after it recommended auto-injectable MS drug ofatumumab for use on the NHS.

Record my learning outcomes

Latest

Inspiring stories related to health, fitness and the pursuit of wellbeing

Share:

More like this

bookmark_icon_off

Tackling type 2

Some 17,000 people across the UK have now completed the NHS Diabetes Prevention Programme.

1 Min Article

bookmark_icon_off

The pollution threat

Some 13 per cent of childhood asthma cases diagnosed globally each year are linked to traffic pollution, according to a new study.

1 Min Article

bookmark_icon_off

Save the date

APTUK's annual APTUK Membership Business Meeting and Showcase will be held on 4 April 2020, in central London.

1 Min Article

bookmark_icon_off

Product update: The guru goes again

The Deep Relief guru advertisement from Mentholatum is back on TV for seven weeks throughout March and April.

1 Min Article

bookmark_icon_off

Reusable inhalers ‘could reduce NHS carbon footprint’

The newly launched reusable Respimat inhalers can be used with up to six refill cartridges.

1 Min Article

bookmark_icon_off

NHS “top priority” for Tories following landslide win

Boris Johnson said the NHS will be the “top priority” for his government after the Conservative's sweeping victory.

2 Min Article

Recommended Learning

bookmark_icon_off

Lower gastrointestinal health

The gastrointestinal tract is suceptible to a variety of conditions, pharmacy teams can be on hand to support customers suffering.

20 Min Module

bookmark_icon_off

Pacemakers

Improve your understanding of pacemakers and look at the do’s and don’ts for managing life with one post surgery.

10 Min Module

bookmark_icon_off

Heartburn and Indigestion

Learn how to identify and help customers manage heartburn and indigestion, from recommending the right products to ease symptoms, to self-care advice and identifying red flags for referral

10 Min Module

bookmark_icon_off

Dementia: part two

Part two of this dementia CPPE module looks at the risk factors associated with dementia and lifestyle factors that can reduce its risk.

12 Min Module

bookmark_icon_off

Burns

Support customers when they have questions about treatments for burns with this pharmacy scenario.

10 Min Module

bookmark_icon_off

How to advise on head lice​

Despite them being so common, many people still don't know how to get rid of head lice. This training will arm you with the facts so that you can help customers choose the best treatments and answer their questions with confidence.

16 Min Module